Literature DB >> 1896500

Enterostatin (Val-Pro-Asp-Pro-Arg), the activation peptide of procolipase, selectively reduces fat intake.

S Okada1, D A York, G A Bray, C Erlanson-Albertsson.   

Abstract

Valine-proline-aspartate-proline-arginine (VPDPR), the amino terminal pentapeptide of pancreatic procolipase, produced a dose-dependent reduction in food intake when injected intraperitoneally into Osborne-Mendel rats that had been starved overnight. This inhibition of feeding was observed when the rats were fed a high-fat diet but not in rats fed a high-carbohydrate, low-fat diet. At higher doses of VPDPR, the inhibition of feeding was maintained for over 6 hours. An equimolar mixture of the free amino acids had no effect on food intake. In rats adapted to a three-choice macronutrient diet, VPDPR inhibited fat intake but had no effect on carbohydrate or protein intake. This selective inhibition of fat intake was observed in both overnight-fasted rats presented with food and in ad-lib-fed rats at the beginning of the dark-onset feeding period. It is suggested that this peptide may be a feedback signal to regulate the intake of dietary fat.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1896500     DOI: 10.1016/0031-9384(91)90349-s

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  14 in total

Review 1.  Pharmacological approaches for the treatment of obesity.

Authors:  José-Antonio Fernández-López; Xavier Remesar; Màrius Foz; Marià Alemany
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Regulation of feeding behavior, gastric emptying, and sympathetic nerve activity to interscapular brown adipose tissue by galanin and enterostatin: the involvement of vagal-central nervous system interactions.

Authors:  Hajime Nagase; Atsushi Nakajima; Hisahiko Sekihara; David A York; George A Bray
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

3.  Enterostatin inhibition of dietary fat intake is modulated through the melanocortin system.

Authors:  Ling Lin; Miejung Park; David A York
Journal:  Peptides       Date:  2006-11-17       Impact factor: 3.750

Review 4.  Central control of body weight and appetite.

Authors:  Stephen C Woods; David A D'Alessio
Journal:  J Clin Endocrinol Metab       Date:  2008-11       Impact factor: 5.958

5.  Enterostatin inhibits insulin secretion from isolated perifused rat islets.

Authors:  C Erlanson-Albertsson; B Hering; R G Bretzel; K Federlin
Journal:  Acta Diabetol       Date:  1994-09       Impact factor: 4.280

6.  Procolipase mRNA: tissue localization and effects of diet and adrenalectomy.

Authors:  S Okada; D A York; G A Bray
Journal:  Biochem J       Date:  1993-06-15       Impact factor: 3.857

Review 7.  Clinical review: Regulation of food intake, energy balance, and body fat mass: implications for the pathogenesis and treatment of obesity.

Authors:  Stephan J Guyenet; Michael W Schwartz
Journal:  J Clin Endocrinol Metab       Date:  2012-01-11       Impact factor: 5.958

8.  Enterostatin deficiency increases serum cholesterol but does not influence growth and food intake in mice.

Authors:  Rita Miller; Dymphna D'Agostino; Charlotte Erlanson-Albertsson; Mark E Lowe
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-07-21       Impact factor: 4.310

Review 9.  Gut fat signaling and appetite control with special emphasis on the effect of thylakoids from spinach on eating behavior.

Authors:  C J Rebello; C E O'Neil; F L Greenway
Journal:  Int J Obes (Lond)       Date:  2015-07-31       Impact factor: 5.095

10.  Effect of a satiating meal on the concentrations of procolipase propeptide in the serum and urine of normal and morbidly obese subjects.

Authors:  R C Bowyer; W M Rowston; A M Jehanli; J H Lacey; J Hermon-Taylor
Journal:  Gut       Date:  1993-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.